Archives: 2019-12-08

KU Leuven responds to allegations of scientific misconduct

KU Leuven has received allegations against one of its researchers regarding possible infringements of scientific integrity. The Commission on Scientific Integrity (CWI) at KU Leuven is looking into the matter. According to a report in De Tijd (paywall), university rector Luc Sels is to call together the Committee on Scientific Integrity following a number of complaints against

Read More


Washington Post publishes a new piece on the unproven regenerative clinic firm the Lung Health Institute.

This article has a number of surprises and new insights. A Tampa-based regenerative clinic accused of using aggressive and unfair marketing tactics to lure the diseased and desperate into spending thousands of dollars on unproven stem cell therapies laid off a “small number of non-medical” employees earlier this week, a company spokesperson confirmed. While it’s

Read More


Sangamo and Pfizer Announce Updated Phase 1/2 Results Showing Sustained Increased Factor VIII Activity Through 44 Weeks Following SB-525 Gene Therapy Treatment

The first two patients treated with the 3e13 vg/kg dose achieved stable Factor VIII (FVIII) levels demonstrating durability in the normal range through 44 and 37 weeks, respectively– All five patients in the 3e13 vg/kg dose cohort achieved normal range FVIII levels within 5-7 weeks following treatment, with no bleeding events with up to 44 weeks

Read More


Buyer beware of this unproven and untested $1 million gene therapy for aging, that might even be harmful to your health

Offshore tests by a startup seek to lengthen people’s telomeres—and their lives. Source MIT Technology Review It’s said that nothing is certain except death and taxes. But doubt has been cast over the former since the 1970s, when scientists picked at the seams of one of the fundamental mysteries of biology: the molecular reasons we

Read More


Hopkins team invents non-viral system for getting gene therapy into cells

Polymer-based nanocontainers could improve the delivery of gene therapies, a Johns Hopkins team reported. One of the most popular methods for inserting therapeutic genes into cells to treat disease is to transport them using a virus that has been stripped of its infectious properties. But those noninfectious viruses can still sometimes touch off dangerous immune

Read More


FDA launches app for healthcare professionals

To report novel uses of existing medicines for patients with difficult-to-treat infectious diseases The US Food and Drug Administration announced the global launch of CURE ID, an Internet-based repository that will allow the clinical community to report their experiences treating difficult-to-treat infectious diseases with novel uses of existing FDA-approved drugs through a website, a smartphone

Read More


FDA sends warning to companies for offering unapproved umbilical cord blood products that may put patients at risk

Liveyon Labs Inc. and Liveyon LLC warned that their stem cell products lack required FDA approval and represent a potential risk to the public health The U.S. Food and Drug Administration has warned Liveyon Labs Inc. (Liveyon Labs) and Liveyon LLC, of Yorba Linda, California, and their presidents and chief executive officers, Roya Panah and John

Read More